European stem cell research in legal shackles

EMBO Journal

Volumn 32, Issue 24, 2013, Pages 3107-3111

  Nielen, Myrthe G ^a   De Vries, Sybe A ^a,b   Geijsen, Niels ^c,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Europa Institute   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ASIA; COURT; EMBRYONIC STEM CELL; ETHICAL DECISION MAKING; EUROPE; EUROPEAN UNION; GERM CELL; HUMAN; HUMAN EMBRYO; IN VITRO STUDY; NEURAL STEM CELL TRANSPLANTATION; NEURAL TUBE DEFECT; OOCYTE; PATENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RIGHT TO LIFE; SPERM; STEM CELL RESEARCH; UNITED STATES;

ANIMALS; ASIA; EMBRYONIC STEM CELLS; EUROPE; HUMANS; MALE; OOCYTES; PATENTS AS TOPIC; PLURIPOTENT STEM CELLS; SPERMATOZOA; STEM CELL RESEARCH; UNITED STATES;

EID: 84890562880     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2013.249     Document Type: Review

References (23)

1. Bonadio E (2012) Biotech patents and morality after Brustle. Eur Intellect Property Rev 34: 433-443
2. Burke S (2012) Interpretive clarification of the concept of ''human embryo'' in the context of the Biotechnology Directive and the implications for patentability: Brustle v Greenpeace eV (C-34/10). Eur Intellect Property Rev 34: 346-350
3. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, Firpo MT, Pera RAR (2004) Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet 13: 727-739
4. Cyranoski D (2013) Stem cells cruise to clinic. Nature 494: 413
5. Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10: 740-749
6. de Vries S (2013) The protection of fundamental rights within Europe's Internal Market after Lisbon - an endeavour for more harmony. In: de Vries S, Bernitz U, Weatherill S (eds) The Protection of Fundamental Rights in the EU after Lisbon. Oxford: Hart Publishing, pp 59-94
7. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156
8. Gavrilov S, Marolt D, Douglas NC, Prosser RW, Khalid I, Sauer MV, Landry DW, Vunjak-Novakovic G, Papaioannou VE (2011) Derivation of two new human embryonic stem cell lines from nonviable human embryos. Stem Cells Int 2011: 765378
9. Gavrilov S, Prosser RW, Khalid I, MacDonald J, Sauer MV, Landry DW, Papaioannou VE (2009) Non-viable human embryos as a source of viable cells for embryonic stem cell derivation. Reprod Biomed Online 18: 301-308
10. Harmon SHE, Laurie G, Courtney A (2013) Dignity, plurality and patentability: the unfinished story of Brustle v Greenpeace. Eur Law Rev 38: 92-106
11. Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M (2012) Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science 338: 971-975
12. Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M (2011) Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 146: 519-532
13. Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana- Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M et al (2008) New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 3: 607-609
14. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634-7638
15. Nakaki F, Hayashi K, Ohta H, Kurimoto K, Yabuta Y, Saitou M (2013) Induction of mouse germ-cell fate by transcription factors in vitro. Nature 501: 222-226
16. Paton M, Denoon A (2011) The ramifications of the Advocate General's Opinion in the Oliver Brüstle case. Eur Intellect Property Rev 33: 590-596
17. Plomer A (2012) After Brustle: EU accession to the ECHR and the future of European patent law. Queen Mary J Intellect Property 2: 110-135
18. Spranger TM (2012) Case C-34/10, Oliver Brüstle v. Greenpeace e.V., Judgment of the Court (Grand Chamber) of 18 October 2011, nyr. Common Market Law Rev 49: 1197-1210
19. Takahashi K, Okita K, Nakagawa M, Yamanaka S (2007a) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2: 3081-3089
20. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007b) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872
21. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676
22. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147
23. Varju M, Sándor J (2012) 'Patenting stem cells in Europe: the challenge of multiplicity in European Union law'. Common Market Law Rev 49: 1007-1038